← Leaderboards
Yin Shen
University Of California, San Francisco
$15,149,672
Attributed
$34,255,406
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.8M · FY2017–25$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,255,406 · 12
By mechanism
R01$11,269,716 · 4
RF1$9,000,748 · 2
UM1$8,365,909 · 1
U01$3,361,246 · 1
R56$1,344,626 · 1
R21$884,521 · 2
Top collaborators
- Li Gan11 shared
- Arnold Kriegstein8 shared
- Hongjun Song7 shared
- Bing Ren6 shared
- Yun Li5 shared
- Nadav Ahituv2 shared
- Eric J Huang2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Arnold Kriegstein$44,761,461
- David Antonetti$16,933,384
- Adam R. Abate$16,378,110
- Tyson Nam Kim$1,276,954
- Douglas Gould$18,350,835
Others in their field
Other Emerging Leaders on “Cell Type”
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Thomas Denny · Duke University$19,381,749
- Tomasz Nowakowski · University Of California, San Francisco$18,472,946
- Hemali Phatnani · New York University School Of Medicine$18,358,586
- Rui M. Costa · Columbia University Health Sciences$13,762,381
Research focus
Cell TypeGene ExpressionGenesAlzheimer&AposGeneticGenetic TranscriptionCellsPhenotypeChromatinGene Expression RegulationElementsRegulatory ElementInduced Pluripotent Stem CellMapsNucleic Acid Regulatory SequencesBiological ProcessAffectEpigenomicsUntranslated RnaLinkInsightMediatingDistalFunctional Genomics
Grant awards (36)
Elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes$2,393,458
RF1 · FY2025 · AG · contact PI
Study of Selective Cell and System Vulnerability in Alzheimer's Disease$1,284,439
R01 · FY2025 · AG
Single Cell Characterization of FTLD-GRN$965,344
R01 · FY2025 · NS
Administrative Supplement: Enhancing cell-type-specific inference with millions of snRNA-seq and deep learning methods$91,474
R01 · FY2025 · AG
2025 Genome Architecture in Cell Fate and Disease Gordon Research Conference and Gordon Research Seminar$28,640
R13 · FY2025 · HG · contact PI
Study of Selective Cell and System Vulnerability in Alzheimer's Disease$1,320,382
R01 · FY2024 · AG
Charting the 3D epigenome in human brain development and diseases$635,746
U01 · FY2024 · DA · contact PI
Charting the 3D epigenome in human brain development and diseases$180,000
U01 · FY2024 · DA · contact PI
Study of Selective Cell and System Vulnerability in Alzheimer's Disease$1,356,754
R01 · FY2023 · AG
Charting the 3D epigenome in human brain development and diseases$636,375
U01 · FY2023 · DA · contact PI
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools$201,875
R21 · FY2023 · DA · contact PI
Elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes$3,716,281
RF1 · FY2022 · AG · contact PI
Single Cell Characterization of FTLD-GRN$2,891,009
RF1 · FY2022 · NS
Study of Selective Cell and System Vulnerability in Alzheimer's Disease$1,344,626
R56 · FY2022 · AG
Charting the 3D epigenome in human brain development and diseases$636,375
U01 · FY2022 · DA · contact PI
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools$242,250
R21 · FY2022 · DA · contact PI
High throughput CRISPR-mediated functional validation of regulatory elements$1,571,946
UM1 · FY2021 · HG · contact PI
Functional characterization of Alzheimer's disease associated genetic variants$831,005
R01 · FY2021 · AG · contact PI
Charting the 3D epigenome in human brain development and diseases$636,375
U01 · FY2021 · DA · contact PI
Transcriptional regulation of BEST1 in retina pigment epithelium.$399,058
R01 · FY2021 · EY · contact PI
High throughput CRISPR-mediated functional validation of regulatory elements$1,552,831
UM1 · FY2020 · HG · contact PI
Functional characterization of Alzheimer's disease associated genetic variants$833,789
R01 · FY2020 · AG · contact PI
Charting the 3D epigenome in human brain development and diseases$636,375
U01 · FY2020 · DA · contact PI
Transcriptional regulation of BEST1 in retina pigment epithelium.$411,400
R01 · FY2020 · EY · contact PI
High throughput CRISPR-mediated functional validation of regulatory elements$1,559,021
UM1 · FY2019 · HG · contact PI
Functional characterization of Alzheimer's disease associated genetic variants$836,490
R01 · FY2019 · AG · contact PI
Transcriptional regulation of BEST1 in retina pigment epithelium.$411,400
R01 · FY2019 · EY · contact PI
Development of massively parallel reporter assays that use cognate promoters$200,521
R21 · FY2019 · HG · contact PI
High throughput CRISPR-mediated functional validation of regulatory elements$1,565,048
UM1 · FY2018 · HG · contact PI
Functional characterization of Alzheimer's disease associated genetic variants$833,263
R01 · FY2018 · AG · contact PI
High throughput CRISPR-mediated functional validation of regulatory elements$549,648
UM1 · FY2018 · HG · contact PI
Transcriptional regulation of BEST1 in retina pigment epithelium.$411,400
R01 · FY2018 · EY · contact PI
Development of massively parallel reporter assays that use cognate promoters$239,875
R21 · FY2018 · HG · contact PI
High throughput CRISPR-mediated functional validation of regulatory elements$1,567,415
UM1 · FY2017 · HG · contact PI
Functional characterization of Alzheimer's disease associated genetic variants$857,493
R01 · FY2017 · AG · contact PI
Transcriptional regulation of BEST1 in retina pigment epithelium.$426,025
R01 · FY2017 · EY · contact PI